Leader Adult Tussin Mucus and Chest Congestion 541 Guaifenesin 200 mg/10mL Liquid
by CARDINAL HEALTH 110, LLC. DBA LEADER · 1 BOTTLE in 1 CARTON (70000-0696-1) / 118 mL in 1 BOTTLE
NDC 70000-0696-01
🏷️ FDA NDC (as labeled)
70000-0696-1
billing pads the package segment with a zero
This package
Also priced by: Medicaid pays $0.0806/unit — full pricing hub ↓
Also comes in:
237 mL 70000-0696-02
OTC
On market
Non-controlled
🗂️ Data synced Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
🆔 Identity & classification
FDA NDC (as labeled)
70000-0696-1
Product NDC
70000-0696
11-digit billing NDC
70000069601
NCPDP billing unit
ML — per mL (volume)
RxCUI
1606850
UNII
495W7451VQ
Application #
M012
SPL Set ID
d7fae410-9c1c-4231-9fde-2c51ad3d7e95
Established class (EPC)
Expectorant
Physiologic effect
Decreased Respiratory Secretion Viscosity; Increased Respiratory Secretions
DEA schedule
Non-controlled
Marketing category
OTC MONOGRAPH DRUG
Marketing status
On market
FDA listing status
Listed (active directory)
Marketing start
2024-09-20
Route
ORAL
Dosage form
LIQUID
Substance
GUAIFENESIN
GPI-14
43200010000910
GCN Seq No
022210
GCN
02512
HICL code
000271
Ingredient (HICL)
Guaifenesin
HIC1 code
B
Therapeutic class — broad (HIC1)
Respiratory System
HIC2 code
B3
Therapeutic class — intermediate (HIC2)
Drugs Affecting Primarily The Trachea And Bronchi
HIC3 code
B3J
Therapeutic class — specific (HIC3)
Expectorants
AHFS code
48:16.00.00
AHFS class
Expectorants
FDB label name
TUSSIN MUCUS-CONG 200 MG/10 ML
FDB brand name
Tussin Mucus-Chest Congestion
Legend status
O — Over-the-counter (OTC) drug or device
Why two NDCs?
The FDA registers this code as 70000-0696-1 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 70000-0696-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.
🏷️ RxNorm drug class
This medicine belongs to the Expectorant class.
Pharmacologic class
Expectorant
Drug family (ATC)
Expectorants
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.
🏭 Manufacturer & labeler
LabelerCARDINAL HEALTH 110, LLC. DBA LEADER
FDA applicationM012 (OTC MONOGRAPH DRUG)
Labeler code70000
First marketedSep 2024
Product typeHuman Otc Drug
Portfolio163 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.
🩺 Clinical
Label name TUSSIN MUCUS-CONG 200 MG/10 ML Ingredient Guaifenesin
📖 What it is MedlinePlus · NLM
Guaifenesin is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a class of medications called expectorants. It works by thinning the mucus in the air passages to make it easier to cough up the mucus and clear the airways.
Read the full MedlinePlus article ↗📗 Our plain-language guide HelloPharmacist
- Guaifenesin is what's called an expectorant — it works to thin and loosen the mucus sitting in your chest and airways. That makes it easier to cough the mucus up and out, so instea...
- What exactly does guaifenesin do for my cough?
- Guaifenesin is meant for short-term use. If your cough isn't getting better after 7 days, keeps coming back, or shows up alongside a fever, rash, or a headache that won't go away,...
- How long can I take it before I should call my doctor?
Patient education
Supplement & herbal interactions
Some supplements/herbs that may interact with Guaifenesin — tap one for details:
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.
💬 Questions about Guaifenesin?
Ask a pharmacist →
Ask a licensed pharmacist directly — free, answered by our team.
💊 What it looks like
Color
Red
FlavorCherry
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.
🧪 Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.
-
UNII XF417D3PSL
Anhydrous citric acid is a sour, crystalline powder derived from citric acid with water removed. In medicines, it acts as a buffer to control pH, adds tartness to improve taste, and helps tablets disintegrate.
-
UNII T9D99G2B1R
Caramel is a brown coloring substance made by heating sugar. It's added to medicines to give them color and sometimes a slight sweet taste without affecting how the drug works.
-
UNII WZB9127XOA
A synthetic red dye used to color medications and make them easier to identify. It serves as a colorant in tablets, capsules, and liquid formulations.
-
UNII PDC6A3C0OX
Glycerin is a clear, thick liquid derived from plant oils or fats. It acts as a humectant to retain moisture, a sweetener, and a solvent in medications.
-
UNII XY6UN3QB6S
A sweetener made from corn starch that contains fructose and glucose. It sweetens the medicine to improve taste and may help preserve the product.
-
UNII L7T10EIP3A
A cooling compound from mint plants used as a flavoring agent and to create a fresh sensation in medicines. It helps mask bitter tastes and improve how the product feels in the mouth.
-
UNII 6DC9Q167V3
Propylene glycol is a clear liquid derived from petroleum or vegetable sources. It acts as a solvent, humectant, and preservative in medicines, helping dissolve active ingredients and maintain product stability.
-
UNII SB8ZUX40TY
Saccharin sodium is an artificial sweetener made from saccharin salt. It's added to medicines to improve taste, especially in liquid formulations for children or bitter drugs.
-
UNII OJ245FE5EU
Sodium benzoate is a salt derived from benzoic acid, a preservative. It's added to medicines to prevent growth of bacteria, fungi, and other microorganisms that could spoil the product.
-
UNII 059QF0KO0R
Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.
10 inactive ingredients listed in the exact product block matched to this NDC.
The official label also statescaramel color, citric acid anhydrous, FD&C red# 40 dye, flavor, glycerin, high fructose corn syrup, menthol, propylene glycol, purified water, saccharine sodium, sodium benzoate.
Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.
Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed —
ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.
💲 Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per mL | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | $0.023 | $2.70 / 118 ml |
| Medicaid paysCMS SDUD · 12 mo | $0.0806 | $9.51 / 118 ml |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
NADAC price history (per mL) — tap or hover for the price & month
▲ Up 3% over the last 9 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.
🔁 Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Rugby Mucus and Chest Congestion 541 200 mg/10mL 00536-1430-97 | Rugby | 1 bottle | $0.023 | — | Availability likely | — |
| Leader Adult Tussin Mucus and Chest Congestion 541 200 mg/10mLthis 70000-0696-01 | CARDINAL | 1 bottle | $0.023 | — | Availability likely | — |
| Tussin 200 mg/10mL 70677-1186-01 | Strategic | 1 bottle | $0.023 | — | Availability likely | — |
| Tussin Mucus and Chest Congestion Sugar Free 200 mg/10mL 82568-0012-04 | AARNA | 1 bottle | $0.023 | — | Availability likely | — |
| QCH Adult Tussin 541 200 mg/10mL 83324-0024-04 | Chain | 1 bottle | $0.023 | — | Availability likely | — |
| Good Neighbor Adult Tussin Mucus and chest congestion 200 mg/10mL 46122-0785-29 | AMERISOURCE | 1 bottle | $0.023 | — | Availability likely | — |
| Revasol Tussin 200 mg/10mL 84379-0313-04 | Rnv | 118 ml | — | — | FDA listed | — |
| Geri-Tussin 200 mg/10mL 57896-0293-16 | Geri-Care | 473 ml | — | — | FDA listed | — |
| Guaifenesin 200 mg/10mL 60687-0863-56 | American | 10 cups | — | — | FDA listed | — |
| Meijer Adult Mucus Plus chest congestion 200 mg/10mL 79481-7430-08 | MEIJER | 1 bottle | — | — | FDA listed | — |
| Quality Choice Adult Tussin Expectorant 200 mg/10mL 83324-0332-04 | QUALITY | 1 bottle | — | — | FDA listed | — |
| CVS Adult Mucus plus Chest Congestion 200 mg/10mL 51316-0437-08 | CVS | 1 bottle | — | — | FDA listed | — |
| Rompe Pecho EX 200 mg/10mL 58593-0829-04 | Efficient | 118 ml | — | — | FDA listed | — |
| Guaifed 200 mg/10mL 73564-0801-04 | Aldama | 118 ml | — | — | FDA listed | — |
| CVS Adult Mucus chest congestion 200 mg/10mL 51316-0743-08 | CVS | 1 bottle | — | — | FDA listed | — |
| Guaifenesin 200 mg/10mL 55154-5780-05 | Cardinal | 5 cups | — | — | FDA listed | — |
| DRx Choice Fruit Punch 200 mg/10mL 68163-0743-04 | Raritan | 1 bottle | — | — | FDA listed | — |
| MAX Tussin Mucus and Chest Congestion 200 mg/10mL 71399-0054-08 | Akron | 1 bottle | — | — | FDA listed | — |
| Adult Tussin 200 mg/10mL 69230-0332-23 | Camber | 1 bottle | — | — | FDA listed | — |
| MAX Tussin Mucus and Chest Congestion Sugar Free 200 mg/10mL 71399-0024-04 | Akron | 1 bottle | — | — | FDA listed | — |
| Guaifenesin 200 mg/10mL 00121-1488-00 | PAI | 10 cups | — | — | FDA listed | — |
| Walgreen Cherry 200 mg/10mL 00363-7043-08 | WALGREEN | 1 bottle | — | — | FDA listed | — |
| Medique Guaicon Insydose 200 mg/10mL 47682-0669-69 | Unifirst | 60 ml | — | — | FDA listed | — |
| Green Guard Instydose Mucus Relief 200 mg/10mL 47682-0769-69 | Unifirst | 60 ml | — | — | FDA listed | — |
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.
⏳ Availability & generic status
🏛️
2024
On the market since
Sep 2024
📍
2026
Currently FDA-listed
2 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.
🗺️ Medicaid utilization & spend
📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for 70000-0696-01, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q2 2025 – Q4 2025 · 3 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
32
Units reimbursed last 4 qtrs
5.9K
Gross reimbursed last 4 qtrs
$477.09
Avg / prescription
$14.91
Avg / unit
$0.0806
Latest quarter Q4 2025
32Rx
Medicaid pays / mL
$0.0806
gross reimbursed
vs
NADAC / mL
$0.0229
acquisition cost
=
Spread
+$0.0577
+252% vs cost
What Medicaid paid per mL (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
Fee-for-service · 32 Rx Managed care · 0 Rx
State Medicaid map
Units reimbursed · per 100k residents
10.993.8
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
Prescriptions—
Units—
Reimbursed—
🏆 Top states by units · per 100k residents
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.
💊 Medicaid utilization by pack size
Medicaid (SDUD) totals over the four most recent reported quarters for every package size of this drug — handy when a specific package (e.g. a starter/titration pack) carries little or no Medicaid volume on its own.
Drug total (last 4 qtrs): 65 Rx · 12,818 units · $828 gross reimbursed
Tap a pack size to open its page. Source: CMS State Drug Utilization Data, last 4 quarters.
🔬 Reported adverse events (FAERS)
Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Leader Adult Tussin Mucus and Chest Congestion 541 (this brand).
Top reported reactions
Age at onset
Reporter sex
Male · 42%
Female · 57%
Unknown · 0%
Serious outcomes
Reports over time (by year) — tap or hover for the count & year
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
📦 Packaging — all sizes for this product
| Package NDC | Description | Per unit | Per pack | Marketing start | Status |
|---|---|---|---|---|---|
| 70000-0696-01 You're viewing this | 1 BOTTLE in 1 CARTON (70000-0696-1) / 118 mL in 1 BOTTLE | $0.0229 / mL | $2.71 | 2024-09-20 | Active |
| 70000-0696-02 | 1 BOTTLE in 1 CARTON (70000-0696-2) / 237 mL in 1 BOTTLE | $0.0183 / mL | $4.33 | 2024-09-20 | Active |
Per mL, this pack runs about 25% above the cheapest pack (NDC 70000-0696-02, $0.0183 vs $0.0229 NADAC).
Pack size FAQ
What quantity is in NDC 70000-0696-01?
NDC 70000-0696-01 is listed by the FDA — 1 bottle in 1 carton / 118 ml in 1 bottle.
What NDC number is used to bill for this package of Leader Adult Tussin Mucus and Chest Congestion 541 Guaifenesin 200 mg/10mL Liquid?
Bill NDC 70000-0696-01 — the 11-digit billing format is 70000069601. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.
Prices are the latest CMS NADAC pharmacy acquisition cost per NDC; per-pack figures are per-unit × pack quantity, shown only when the pack is denominated in the same measure NADAC prices.
📄 FDA label — Drug Facts FDA SPL
The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage
⏱️ Dosage and Administration
⚠️ Warnings
🧪 Active Ingredient
🧪 Inactive Ingredients
🎯 Purpose
🎯 Indications and Usage ▾
USE(S) helps loosen phlegm(mucus) and thin bronchial secretions to drain bronchial tubes
⏱️ Dosage and Administration ▾
DIRECTIONS shake well before using do not take more than 6 doses in any 24-hour period measure only with dosing cup provided keep dosing cup with product ml=milliliter this adult product is not intended for use in children under 12 years of age Age Dose adults & children 12 years & over 10 mL to 20 mL every 4 hours children under 12 years ask a doctor
⚠️ Warnings ▾
WARNINGS .
🧪 Active Ingredient ▾
ACTIVE INGREDIENT(S) Guaifenesin, USP 200 mg
🧪 Inactive Ingredients ▾
INACTIVE INGRADIENTS caramel color, citric acid anhydrous, FD&C red# 40 dye, flavor, glycerin, high fructose corn syrup, menthol, propylene glycol, purified water, saccharine sodium, sodium benzoate.
🎯 Purpose ▾
PURPOSE Expectorant
No label section mentions that — try another word, or open the full label on DailyMed below.
Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA.
Prefer the government’s original formatting? View this label on DailyMed ↗
For educational and professional reference only — not medical advice. Pricing reflects published
NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.